Recent FDA review process of inconclusive clinical studies creates a potentially unhealthy decision-making environment for patients needing gadolinium-enhanced MRIs.
Orest Boyko, MD, PhD
Advertisement
Articles by Orest Boyko, MD, PhD
Advertisement
Latest Updated Articles
U.S. Patients Left Fending For Themselves with Gadolinium Safety RisksDecember 11th 2017
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Molecular Imaging in Focus: SNMMI: Can a New Total Body PET Scanner Slash Scan Times and Bolster Sensitivity?
2
Molecular Imaging in Focus: PSMA PET Radiotracers and Urinary Radioactivity: What Head-to-Head Prospective Multicenter Research Reveals
3
FDA Clears AI Software for Automated Contouring in Radiation Oncology
4
Mammography Study Shows Impact of AI-Powered Slab Reconstruction with DBT
5